Sales and Marketing

Showing 15 posts of 11524 posts found.

LEO Pharma Selects Veeva CRM for Pan-European Deployments

March 1, 2011 Sales and Marketing veeva

BARCELONA, SPAIN — 1 March, 2011 – LEO Pharma, a leading global pharmaceutical company specialising in dermatology and critical care, …
viiv_gsk_pfizer_david_redfern

David Redfern appointed ViiV chairman

February 28, 2011 Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.
black_swan_luke_mcdermott

Black Swan Analysis appoints Luke McDermott

February 28, 2011 Sales and Marketing Black Swan Analysis, Luke McDermott, appointment, sales and marketing

Maidenhead, UK-based Black Swan Analysis has expanded its analysis and forecasting team with the appointment of Luke McDermott.He joins the …

AZ opens new global HQ in London

February 28, 2011 Medical Communications, Sales and Marketing AZ, AstraZeneca, London

AstraZeneca has moved its London global headquarters from Mayfair to new, larger premises in Paddington. The new offices are located …

Healthcare IT and patients: lessons from the NHS experience

February 28, 2011 Medical Communications, Sales and Marketing Healthcare IT, NHS, NHS IT, electronic patient records, online health information

Many countries are investing heavily in electronic health records and health information exchange to drive improvements in the quality of …

Vertex’s cystic fibrosis drug shows huge promise

February 28, 2011 Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …

Working Life: BMS UK’s market access director Patrick Hopkinson

February 24, 2011 Business Services, Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, Patrick Hopkinson, Working Life, recruitment

Patrick Hopkinson, director of market access and external affairs at Bristol-Myers Squibb UK, talks to Pharmafocus about how he got …
Abbott's Humira (adalimumab)

Abbott wins $1.7bn Humira case

February 24, 2011 Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis

Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …
Roche's Avastin (bevacizumab)

NICE yes for Votrient, no to Avastin

February 23, 2011 Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer

NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …
ge_healthcare_kieran_murphy

Kieran Murphy to head up life sciences for GE Healthcare

February 23, 2011 Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing

GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …

AstraZeneca plans $150m plant in Russia

February 22, 2011 Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing

AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …

Four steps to turn around a flagging pharma brand

February 21, 2011 Sales and Marketing MSI, branding, brands, marketing

The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …
idea_michael_morgan-curran

Idea Pharma boosts UK and US teams

February 21, 2011 Sales and Marketing IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketing

Idea Pharma has made new appointments to its UK- and US-based teams

Astellas to commercialise new kidney cancer drug in Europe

February 21, 2011 Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib

Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …
Merck KGaA

Merck KGaA sales soar

February 21, 2011 Sales and Marketing 2010 pharma results, Cladribine, Merck KGaA, Merck Serono, Movectro

Merck KGaA’s sales jumped last year by nearly a fifth as recent acquisitions and strong growth on core products set …
The Gateway to Local Adoption Series

Latest content